Flagship’s AI biotech Generate lands $65M upfront in Novartis deal, as first clinical readouts near

In Today’s News: Generate:Biomedicines and Novartis announced a partnership to develop various protein therapies, with Novartis investing $65 million upfront. The collaboration will focus on protein-based therapeutics, leveraging AI for rapid and efficient drug development. Origin: Endpoints | Andrew Dunn…






